Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?
about
De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinomaNon-surgical interventions for human papilloma virus-positive local advanced oropharyngeal squamous cell cancerImmune biomarkers of anti-EGFR monoclonal antibody therapyTargeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments.EGFR inhibitors and autophagy in cancer treatment.Combination of phosphotidylinositol-3-kinase targeting with cetuximab and irradiation: A preclinical study on an orthotopic xenograft model of head and neck cancer.Whole exome sequencing identifies mTOR and KEAP1 as potential targets for radiosensitization of HNSCC cells refractory to EGFR and β1 integrin inhibition.EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas.
P2860
Q24200362-4371275F-1293-451B-AFC9-B3406C9F2458Q24202687-498FB2AE-AD68-4D87-A438-DDCD23E7427DQ34723594-B4EFCF2B-CDBD-4F47-9A19-981DAAC4C12EQ38155932-F6A09FC7-11A9-431B-BE7B-856DB8A78519Q38257898-C57A921F-EACF-4E9D-BEDA-3882B1A87BD8Q38752793-71DDE9E4-2874-455B-9258-C09A6EFCB920Q53688963-1ABEB464-DEEA-45CC-97E4-A7DA1C1C0BDFQ54495025-58E3396D-6D07-4A9D-8164-D6FB3F46E248
P2860
Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cetuximab in the management of ...... panding the treatment options?
@en
Cetuximab in the management of ...... panding the treatment options?
@nl
type
label
Cetuximab in the management of ...... panding the treatment options?
@en
Cetuximab in the management of ...... panding the treatment options?
@nl
prefLabel
Cetuximab in the management of ...... panding the treatment options?
@en
Cetuximab in the management of ...... panding the treatment options?
@nl
P2093
P1476
Cetuximab in the management of ...... panding the treatment options?
@en
P2093
Jan B Vermorken
Jean Bourhis
Jean-Louis Lefebvre
P304
P356
10.1016/J.EJCA.2010.05.015
P577
2010-06-17T00:00:00Z